Prot #APL2-307: An Open-Label, Non-Randomized, Multi-Center Extension Study to Evaluate the Long-Term Safety and Efficacy of APL-2 in the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Project: Research project

Project Details

StatusActive
Effective start/end date6/29/206/29/23

Funding

  • Biorasi, LLC (Prot #APL2-307)
  • Apellis Pharmaceuticals, Inc. (Prot #APL2-307)